India Targeted China Trade Barriers at Market Access

The government is countering export limitations by incentivizing domestic production of key pharmaceuticals.

Updated on Sept. 26, 2026 in Economic Policy

Isometric editorial illustration of stacked metal shipping containers on a dock, representing global trade and industrial supply chains.
India is pivoting to domestic pharmaceutical production and alternative trade routes after facing persistent market access barriers in China. AI Illustration. Upload story photo >

Live Poll

Should the government prioritize domestic manufacturing to reduce dependence on foreign trade?

Finance Minister Nirmala Sitharaman highlighted that China currently denies direct market access for Indian goods like buffalo meat and generic drugs. To bypass these barriers, Indian exporters have been routing products through Vietnam.

Why it matters

China's restricted access for high-value exports and historical predatory pricing have caused India to lose its lead in pharmaceutical ingredients. The government is responding by shifting toward domestic manufacturing to reduce import reliance and strengthen industrial self-sufficiency.

States currently face a 3% GSDP borrowing ceiling, while 80% of tax revenue is consumed by committed expenditures. Only 20% of tax collections remain available for capital investments to drive growth.

The players

Nirmala Sitharaman

As the Finance Minister of India, she oversees national fiscal policy and budgetary incentives for domestic industrial production.

The details

Indian exporters frequently route goods through Vietnam to reach Chinese consumers after being blocked from direct access. Meanwhile, the Indian government uses budget incentives to bolster the domestic production of active pharmaceutical ingredients. This strategy aims to reclaim production leadership lost to predatory pricing and secure long-term supply chains.

Timeline

  1. September 25, 2026: Finance Minister Nirmala Sitharaman addressed trade barriers at the Bharat Shakti Pondy Lit Fest.

Money Landscape

This move follows the 3 percent GSDP borrowing ceiling currently governing state fiscal health. It marks a shift in trade strategy as the nation balances limited capital investment funds against the goal of expanding domestic manufacturing.

Readers should watch for potential impacts on drug pricing and commodity costs as the country shifts toward domestic supply chains. Consult with a financial professional to understand how shifting industrial policy may affect your regional market sector.

The takeaway

India is actively working to bypass international trade hurdles by strengthening domestic production capabilities. Keep an eye on local manufacturing incentives that could signal shifts in the cost of pharmaceutical and industrial goods.

Further reading

Learn more about the latest developments in Economic Policy.

Live Poll

Should the government prioritize domestic manufacturing to reduce dependence on foreign trade?